Crown Laboratories, Inc. acquired the target/assets from Revance Therapeutics, Inc. in a acquisition on not available.
Deal value was 314614320 Sector: Healthcare; Location: USA.
On the acquirer side, not available advised, led by Marshall Shaffer, Ed Lee, Josh Kogan, Andrew Norwich, Monica Ruiz, Matthew Burner, Jordan Murray, Juliet Anderson, Justin Samson, Chris Stoj, Jason Kanner, Chad Davis, Angela Hagerman, Kaitlin Schock, Daly Brower, Scott Price, Anthony Ji, Grace Zagorskis, Julia Danforth, Pippa Bond, Van Whiting, Sarah Yang, Elise Wang, Albert Yung Kim, Mariana del Carmen Fernandez, Jay Lefkowitz, Jeff Goldfine.
Generated by AI, original source from - Data is in progress
Revance Therapeutics, Inc. advisor
Firm name is in progress
Found it useful? Spread the word.
Kirkland & Ellis advises Crown Laboratories on its acquisition of Revance Therapeutics for $314.22 million. | The Sponsor - The Sponsor
